JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB219590

Anti-Caspase-9 antibody [E23] - BSA and Azide free

Be the first to review this product! Submit a review

|

(45 Publications)

Rabbit Recombinant Monoclonal Caspase-9 antibody. Carrier free. Suitable for IHC-P, IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 45 publications.

View Alternative Names

MCH6, CASP9, Caspase-9, CASP-9, Apoptotic protease Mch-6, Apoptotic protease-activating factor 3, ICE-like apoptotic protease 6, APAF-3, ICE-LAP6

8 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cervical carcinoma tissue labelling Caspase 9 with unpurified ab32539 at a dilution of 1/50.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32539).

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human skeletal muscle tissue labelling Caspase-9 with purified ab32539 at 1/250. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32539).

Flow Cytometry (Intracellular) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)

Intracellular Flow Cytometry analysis of K562 cells labelling Caspase-9 with purified ab32539 at 1/250 (red). Cells were fixed with 100% methanol. A FITC-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32539).

Immunocytochemistry/ Immunofluorescence - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)

Immunocytochemistry/Immunofluorescence analysis of HepG2 cells labelling Caspase-9 with purified ab32539 at 1/500. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) were also used.

Control 1 : primary antibody (1/500) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000).

Control 2 : ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000).

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32539).

Flow Cytometry (Intracellular) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)

Overlay histogram showing K562 cells stained with unpurified ab32539 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (unpurified ab32539, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was anti-rabbit DyLight® 488 (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in K562 cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween used under the same conditions.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32539).

Immunoprecipitation - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)
  • IP

Unknown

Immunoprecipitation - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)

ab32539 (purified) at 1/80 immunoprecipitating Caspase-9 in HeLa whole cell lysate.

Lane 1 (input) : HeLa whole cell lysate (10µg)

Lane 2 (+) : ab32539 + HeLa whole cell lysate.

Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab32539 in HeLa whole cell lysate.

For western blotting, a HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG was used as the secondary antibody (1/1500).

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32539).

All lanes:

Immunoprecipitation - Anti-Caspase-9 antibody [E23] (<a href='/en-us/products/primary-antibodies/caspase-9-antibody-e23-ab32539'>ab32539</a>)

Predicted band size: 46 kDa

Observed band size: 46 kDa

false

Western blot - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)
  • WB

Lab

Western blot - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)

False colour image of Western blot : Anti-Caspase-9 antibody [E23] staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab32539 was shown to bind specifically to Caspase-9. A band was observed at 45 kDa in wild-type THP-1 cell lysates with no signal observed at this size in CASP9 knockout cell line ab276122 (knockout cell lysate ab284219). To generate this image, wild-type and CASP9 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-Caspase-9 antibody [E23] (<a href='/en-us/products/primary-antibodies/caspase-9-antibody-e23-ab32539'>ab32539</a>) at 1/1000 dilution

Lane 1:

Wild-type THP-1 cell lysate at 20 µg

Lane 2:

CASP9 knockout THP-1 cell lysate at 20 µg

Lane 2:

Western blot - Human CASP9 knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-casp9-knockout-thp-1-cell-line-ab276122'>ab276122</a>)

Lane 3:

HeLa cell lysate at 20 µg

Predicted band size: 46 kDa

Observed band size: 45 kDa

false

Western blot - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)
  • WB

CiteAb

Western blot - Anti-Caspase-9 antibody [E23] - BSA and Azide free (AB219590)

Caspase-9 western blot using anti-Caspase-9 antibody [E23] - BSA and Azide free ab219590. Publication image and figure legend from Jiang, S., Zou, Z., et al., 2015, PLoS One, PubMed 26176608.

ab219590 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab219590 please see the product overview.

mTOR inhibitors combined with glycolysis inhibitor induced apoptosis in lung cancer cells.(a) A549 cells were pretreated with 5 mM 2DG for 1 h, and then cells were treated with 8 μM rapamycin or 5 μM AZD2014 for additional 48 h respectively, cell apoptosis was then examined by using an Annexin V-FITC/PI staining assay kit. (b) A549 cells were pretreated with 5 mM 2DG for 1 h, and then treated with 5 μM AZD2014 for additional 48 h, as well as the cells were untreated and treated with 5 mM 2-DG or 5 μM AZD2014 alone for 48 h before harvesting cellular proteins. (c) A549 cells were pretreated with 5 mM 2DG for 1 h, and then treated with 5 μM AZD2014 for additional 48 h. Meanwhile, the cells were untreated and treated with 5 mM 2DG or 5 μM AZD2014 alone for 48 h before harvesting cellular proteins. All cell lysates were probed for the apoptosis–associated proteins such as BAX, BCL-2, cleaved PARP, cleaved caspase-3 and caspase 9 by Western blot. The similar results were obtained from other two independent experiments, and data shown are the representatives of the three experiments.

false

  • Unconjugated

    Anti-Caspase-9 antibody [E23]

  • 578 PE

    PE Anti-Caspase-9 antibody [E23]

  • 660 APC

    APC Anti-Caspase-9 antibody [E23]

  • HRP

    HRP Anti-Caspase-9 antibody [E23]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Caspase-9 antibody [E23]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Caspase-9 antibody [E23]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Caspase-9 antibody [E23]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-Caspase-9 antibody [E23]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

E23

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

WB, ICC/IF, IHC-P, Flow Cyt (Intra), IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody should recognise both the pro-[40kDa] form and p35 cleaved form of Caspase-9.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>We recommend overnight incubation at 4°C.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-low-endotoxin-azide-free-ab199376'>ab199376</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" } } }

Product details

ab219590 is the carrier-free version of ab32539.

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates effector caspases caspase-3 (CASP3) or caspase-7 (CASP7). Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-ribose) polymerase (PARP). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed : 36758105, PubMed : 36758106).. Isoform 2. Lacks activity is an dominant-negative inhibitor of caspase-9.
See full target information CASP9

Publications (45)

Recent publications for all applications. Explore the full list and refine your search

Molecular medicine reports 24: PubMed34651659

2021

miR‑302d‑3p regulates the viability, migration and apoptosis of breast cancer cells through regulating the TMBIM6‑mediated ERK signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yanru Liao,Zhenxiong Qiu,Ling Bai

Molecular medicine reports 24: PubMed34278485

2021

FOXG1 improves mitochondrial function and promotes the progression of nasopharyngeal carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Huajun Xi,Zhengxiang He,Cao Lv

Oncology letters 21:387 PubMed33777210

2021

Knockdown of CLN5 inhibits the tumorigenic properties of glioblastoma cells via the Akt/mTOR signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jiexia Xing,Ying Li,Huilan Zhao

Molecular medicine reports 23: PubMed33236144

2020

miR‑18a‑5p promotes melanoma cell proliferation and inhibits apoptosis and autophagy by targeting EPHA7 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Yunlong Guo,Wenli Shi,Ruihua Fang

Bioscience reports 40: PubMed33185692

2020

Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Chunlei Wu,Jiange Zhang

Experimental and therapeutic medicine 20:3244-3252 PubMed32855694

2020

Hydrogen peroxide induces nucleus pulposus cell apoptosis by ATF4/CHOP signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yi Liu

Cancer biology & therapy 21:758-766 PubMed32543324

2020

LINC00641/miR-4262/NRGN axis confines cell proliferation in glioma.

Applications

Unspecified application

Species

Unspecified reactive species

Jinghui Yang,Duo Yu,Xueshibojie Liu,E Changyong,Shan Yu

Cell proliferation 53:e12823 PubMed32515533

2020

LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Xu,Baohua Yang,Lifeng Wang,Yunheng Zhu,Xiuxiang Zhu,Ziyin Xia,Zhen Zhao,Ling Xu

Cancer biology & therapy 21:604-614 PubMed32329664

2020

LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Changsheng Shi,Qing Yang,Songsong Pan,Xingcheng Lin,Gending Xu,Ya Luo,Bingru Zheng,Xiangpang Xie,Mingxu Yu

Journal of cellular biochemistry 121:4601-4611 PubMed32277517

2020

Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p/ORMDL3 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xia Liu,Jingyong Song,Yu Kang,Yaojia Wang,Anyue Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com